Skip to main content
Log in

Endoscopic ultrasonography for pancreatic solid lesions

  • Special Feature: Review Article
  • Ultrasonographic diagnosis of pancreatic diseases-This is all you need
  • Published:
Journal of Medical Ultrasonics Aims and scope Submit manuscript

Abstract

The incidence and mortality rates of pancreatic cancer, which has a poor prognosis, are rising rapidly. Endoscopic ultrasonography (EUS) provides superior spatial resolution compared with other imaging modalities such as transabdominal ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), and it is considered among the most reliable and efficient diagnostic modalities for pancreatic diseases. In this review, we show that EUS is useful for detection of pancreatic solid lesions and staging of pancreatic cancer. EUS also plays an important role in screening patients with high-risk factors for pancreatic cancer. Although EUS is useful for detection of small pancreatic lesions, pancreatic lesions are difficult to characterize using this modality, because most pancreatic solid lesions appear hypoechoic on EUS. From this point of view, contrast-enhanced harmonic EUS (CH-EUS) plays an important role in the differential diagnosis of pancreatic lesions. EUS and CH-EUS are also useful for staging pancreatic cancer. Moreover, EUS-guided fine-needle aspiration (EUS-FNA) is superior to other modalities in terms of cytopathological diagnosis. Although EUS-FNA has a high diagnostic ability for pancreatic cancer, the combination of EUS-FNA and CH-EUS improves the diagnostic ability by decreasing the number of false-negative cases. Thus, conventional EUS, EUS-FNA, and CH-EUS are essential in clinical practice for the diagnosis of pancreatic solid lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Adsay NV, Basturk O, Klimstra DS, et al. Pancreatic pseudotumors: non-neoplastic solid lesions of the pancreas that clinically mimic pancreas cancer. Semin Diagn Pathol. 2004;21:260–7.

    PubMed  Google Scholar 

  2. Detlefsen S, Sipos B, Feyerabend B, et al. Pancreatic fibrosis associated with age and ductal papillary hyperplasia. Virchows Arch. 2005;447:800–5.

    PubMed  Google Scholar 

  3. Zamboni G, Lüttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004;445:552–63.

    PubMed  Google Scholar 

  4. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    PubMed  Google Scholar 

  5. Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database. J Am Coll Surg. 1999;189:1–7.

    PubMed  CAS  Google Scholar 

  6. Kersting S, Roth J, Bunk A. Transabdominal contrast-enhanced ultrasonography of pancreatic cancer. Pancreatology. 2011;11:20–7.

    PubMed  Google Scholar 

  7. Hiotis SP, Klimstra DS, Conlon KC, et al. Results after pancreatic resection for metastatic lesions. Ann Surg Oncol. 2002;9:675–9.

    PubMed  Google Scholar 

  8. Reddy S, Wolfgang CL. The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol. 2009;10:287–93.

    PubMed  Google Scholar 

  9. Benning TL, Silverman JF, Berns LA, et al. Fine needle aspiration of metastatic and hematologic malignancies clinically mimicking pancreatic carcinoma. Acta Cytol. 1992;36:471–6.

    PubMed  CAS  Google Scholar 

  10. Low G, Panu A, Millo N, et al. Multimodality imaging of neoplastic and nonneoplastic solid lesions of the pancreas. Radiographics. 2011;31:993–1015.

    PubMed  Google Scholar 

  11. American Cancer Society. Cancer facts and figures 2017 [Internet]. American Cancer Society, Inc., Atlanta (2017) (cited 6 Jan 2019). https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/cancer-facts-and-figures-2017.pdf.

  12. Center for Cancer Control and Information Services. National Cancer Center Japan, Tokyo (revised 7 Dec 2018). https://ganjoho.jp/reg_stat/statistics/stat/summary.html.

  13. Ahmad NA, Kochman ML, Lewis JD, et al. Endosonography is superior to angiography in the preoperative assessment of vascular involvement among patients with pancreatic carcinoma. J Clin Gastroenterol. 2001;32:54–8.

    PubMed  CAS  Google Scholar 

  14. DeWitt J, Devereaux B, Chriswell M, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med. 2004;141:753–63.

    PubMed  Google Scholar 

  15. Kato T, Tsukamoto Y, Naitoh Y, et al. Ultrasonographic and endoscopic ultrasonographic angiography in pancreatic mass lesions. Acta Radiol. 1995;36:381–7.

    PubMed  CAS  Google Scholar 

  16. Sanchez MV, Varadarajulu S, Napoleon B. EUS contrast agents: what is available, how do they work, and are they effective? Gastrointest Endosc. 2009;69:571–7.

    Google Scholar 

  17. Kitano M, Kudo M, Sakamoto H, et al. Preliminary study of contrast-enhanced harmonic endosonography with second-generation contrast agents. J Med Ultrason. 2008;35:11–8.

    Google Scholar 

  18. Vilmann P, Jacobsen GK, Henriksen FW, et al. Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease. Gastrointest Endosc. 1992;38:172–3.

    PubMed  CAS  Google Scholar 

  19. Helmstaedter L, Riemann JF. Pancreatic cancer—EUS and early diagnosis. Langenbecks Arch Surg. 2008;393:923–7.

    PubMed  Google Scholar 

  20. Kudo M. Various contrast-enhanced imaging modes after administration of Levovist. In: Kudo M, editor. Contrast harmonic imaging in the diagnosis and treatment of hepatic tumors. Tokyo: Springer; 2003. p. 22–30.

    Google Scholar 

  21. Kitano M, Sakamoto H, Komaki T, et al. New techniques and future perspective of EUS for the differential diagnosis of pancreatic malignancies: contrast harmonic imaging. Dig Endosc. 2011;23:46–50.

    PubMed  Google Scholar 

  22. Kitano M, Sakamoto H, Matsui U, et al. A novel perfusion imaging technique of the pancreas: contrast-enhanced harmonic EUS (with video). Gastrointest Endosc. 2008;67:141–50.

    PubMed  Google Scholar 

  23. Sakamoto H, Kitano M, Suetomi Y, et al. Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas. Ultrasound Med Biol. 2008;34:525–32.

    PubMed  Google Scholar 

  24. Reddy NK, Ioncica AM, Saftoiu A, et al. Contrastenhanced endoscopic ultrasonography. World J Gastroenterol. 2011;17:42–8.

    PubMed  PubMed Central  Google Scholar 

  25. Matsubara H, Itoh A, Kawashima H, et al. Dynamic quantitative evaluation of contrast-enhanced endoscopic ultrasonography in the diagnosis of pancreatic diseases. Pancreas. 2011;40:1073–9.

    PubMed  Google Scholar 

  26. Wang KX, Ben QW, Jin ZD, et al. Assessment of morbidity and mortality associated with EUS-guided FNA: a systematic review. Gastrointest Endosc. 2011;73:283–90.

    PubMed  Google Scholar 

  27. Eloubeidi MA, Tamhane A. EUS-guided FNA of solid pancreatic masses: a learning curve with 300 consecutive procedures. Gastrointest Endosc. 2005;61:700–8.

    PubMed  Google Scholar 

  28. Glasbrenner B, Schwarz M, Pauls S, et al. Prospective comparison of endoscopic ultrasound and endoscopic retrograde cholangiopancreatography in the preoperative assessment of masses in the pancreatic head. Dig Surg. 2000;17:468–74.

    PubMed  CAS  Google Scholar 

  29. Lanke G, Ali FS, Lee JH. Clinical update on the management of pseudopapillary tumor of pancreas. World J Gastrointest Endosc. 2018;10:145–55.

    PubMed  PubMed Central  Google Scholar 

  30. Zimmer T, Scherübl H, Faiss S, et al. Endoscopic ultrasonography of neuroendocrine tumours. Digestion. 2000;62:45–50.

    PubMed  Google Scholar 

  31. King CM, Reznek RH, Dacie JE, Wass JA. Imaging islet cell tumours. Clin Radiol. 1994;49:295–303.

    PubMed  Google Scholar 

  32. DeWitt J, Jowell P, Leblanc J, et al. EUS-guided FNA of pancreatic metastases: a multicenter experience. Gastrointest Endosc. 2005;61:689–96.

    PubMed  Google Scholar 

  33. Kitano M, Yoshida T, Itonaga M, et al. Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer. J Gastroenterol. 2019;54:19–32.

    PubMed  Google Scholar 

  34. Legmann P, Vignaux O, Dousset B, et al. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol. 1998;170:1315–22.

    PubMed  CAS  Google Scholar 

  35. Sakamoto H, Kitano M, Suetomi Y, et al. Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas. Ultrasound Med Biol. 2008;34:525–32.

    PubMed  Google Scholar 

  36. Yasuda K, Mukai H, Nakajima M, et al. Staging of pancreatic carcinoma by endoscopic ultrasonography. Endoscopy. 1993;25:151–5.

    PubMed  CAS  Google Scholar 

  37. Ardengh JC, de Paulo GA, Ferrari AP. Pancreatic carcinomas smaller than 30 cm endosonography (EUS) in diagnosis, staging and prediction of resectability. HPB (Oxford). 2003;5:226–30.

    CAS  Google Scholar 

  38. Jemaa Y, Houissa F, Trabelsi S, et al. Endoscopic ultrasonography versus helical CT in diagnosis and staging of pancreatic cancer. Tunis Med. 2008;86:346–9.

    PubMed  Google Scholar 

  39. Kanno A, Masamune A, Hanada K, et al. Multicenter study of early pancreatic cancer in Japan. Pancreatology. 2018;18:61–7.

    PubMed  Google Scholar 

  40. Krishna SG, Rao BB, Ugbarugba E, et al. Diagnostic performance of endoscopic ultrasound for detection of pancreatic malignancy following an indeterminate multidetector CT scan: a systemic review and meta-analysis. Surg Endosc. 2017;31:4558–67.

    PubMed  Google Scholar 

  41. Dietrich CF, Sahai AV, D’Onofrio M, et al. Differential diagnosis of small solid pancreatic lesions. Gastrointest Endosc. 2016;84:933–40.

    PubMed  Google Scholar 

  42. Hanada K, Okazaki A, Hirano N, et al. Diagnostic strategies for early pancreatic cancer. J Gastroenterol. 2015;50:147–54.

    PubMed  Google Scholar 

  43. Gangi A, Malafa M, Klapman J. Endoscopic ultrasound-based pancreatic cancer screening of high-risk individuals: a prospective observational trial. Pancreas. 2018;47:586–91.

    PubMed  Google Scholar 

  44. Thiruvengadam SS, Chuang J, Huang R, et al. Chronic pancreatitis changes in high-risk individuals for pancreatic ductal adenocarcinoma. Gastrointest Endosc. 2018;15:85. https://doi.org/10.1016/j.gie.2018.08.029.

    Article  Google Scholar 

  45. Kamata K, Kitano M, Kudo M, et al. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms. Endoscopy. 2014;46:22–9.

    PubMed  Google Scholar 

  46. Rösch T, Lorenz R, Braig C, et al. Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc. 1991;37:347–52.

    PubMed  Google Scholar 

  47. Soriano A, Castells A, Ayuso C, et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol. 2004;99:492–501.

    PubMed  Google Scholar 

  48. Ramsay D, Marshall M, Song S, et al. Identification and staging of pancreatic tumours using computed tomography, endoscopic ultrasound and mangafodipir trisodium-enhanced magnetic resonance imaging. Australas Radiol. 2004;48:154–61.

    PubMed  Google Scholar 

  49. Bhutani MS, Hawes RH, Hoffman BJ. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc. 1997;45:474–9.

    PubMed  CAS  Google Scholar 

  50. Nawaz H, Fan CY, Kloke J, et al. Performance characteristics of endoscopic ultrasound in the staging of pancreatic cancer: a meta-analysis. JOP. 2013;14:484–97.

    PubMed  Google Scholar 

  51. Sawhney MS, Debold SM, Kratzke RA, et al. Central intranodal blood vessel: a new EUS sign described in mediastinal lymph nodes. Gastrointest Endosc. 2007;65:602–8.

    PubMed  Google Scholar 

  52. Bodea R, Seicean A, Vasile T, et al. Role of computer tomography and endoscopic ultrasonography in assessing portal and superior mesenteric vessels invasion in cephalo-pancreatic adenocarcinoma. Ann Ital Chir. 2017;88:336–41.

    PubMed  Google Scholar 

  53. Rösch T, Dittler HJ, Lorenz R, et al. The endosonographic staging of pancreatic carcinoma. Dtsch Med Wochenschr. 1992;117:563–9.

    PubMed  Google Scholar 

  54. James PD, Meng ZW, Zhang M, et al. The incremental benefit of EUS for identifying unresectable disease among adults with pancreatic adenocarcinoma: a meta-analysis. PLoS One. 2017;12:e0173687.

    PubMed  PubMed Central  Google Scholar 

  55. Sofuni A, Itoi K, Tsuji S, et al. New advances in contrast-enhanced ultrasonography for pancreatic disease—usefulness of the new generation contrast agent and contrast-enhanced ultrasonographic imaging method. J Gastroenterol Hepatol Res. 2012;1:233–40.

    Google Scholar 

  56. Fusaroli P, D’Ercole MC, De Giorgio R, et al. Contrast harmonic endoscopic ultrasonography in the characterization of pancreatic metastases (with video). Pancreas. 2014;43:584–7.

    PubMed  Google Scholar 

  57. Kitano M, Kudo M, Yamao K, et al. Characterization of small solid tumors in the pancreas: the value of contrast-enhanced harmonic endoscopic ultrasonography. Am J Gastroenterol. 2012;107:303–10.

    PubMed  Google Scholar 

  58. Yamashita Y, Kato J, Ueda K, et al. Contrast-enhanced endoscopic ultrasonography for pancreatic tumors. Biomed Res Int. 2015;2015:8 (Article ID 491782).

    Google Scholar 

  59. Yamashita Y, Shimokawa T, Napoléon B, et al. Value of contrast-enhanced harmonic endoscopic ultrasonography with enhancement pattern for diagnosis of pancreatic cancer: a meta-analysis. Dig Endosc. 2018;31:125–33.

    Google Scholar 

  60. Bunganič B, Laclav M, Dvořáková T, et al. Accuracy of EUS and CEH EUS for the diagnosis of pancreatic tumours. Scand J Gastroenterol. 2018;5:1–6.

    Google Scholar 

  61. Imazu H, Uchiyama Y, Matsunaga K, et al. Contrast-enhanced harmonic EUS with novel ultrasonographic contrast (Sonazoid) in the preoperative T-staging for pancreaticobiliary malignancies. Scand J Gastroenterol. 2010;45:732–8.

    PubMed  Google Scholar 

  62. Miyata T, Kitano M, Omoto S, et al. Contrast-enhanced harmonic endoscopic ultrasonography for assessment of lymph node metastases in pancreatobiliary carcinoma. World J Gastroenterol. 2016;22:3381–91.

    PubMed  PubMed Central  Google Scholar 

  63. Yamashita Y, Ueda K, Itonaga M, et al. Tumor vessel depiction with contrast-enhanced endoscopic ultrasonography predicts efficacy of chemotherapy in pancreatic cancer. Pancreas. 2013;42:990–5.

    PubMed  CAS  Google Scholar 

  64. Hijioka S, Hara K, Mizuno N, et al. Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms. J Gastroenterol. 2016;51:923–30.

    PubMed  PubMed Central  CAS  Google Scholar 

  65. Chen G, Liu S, Zhao Y, et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer: a meta-analysis. Pancreatology. 2013;13:298–304.

    PubMed  Google Scholar 

  66. Uehara H, Ikezawa K, Kawada N, et al. Diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration for suspected pancreatic malignancy in relation to the size of lesions. J Gastroenterol Hepatol. 2011;26:1256–61.

    PubMed  Google Scholar 

  67. Siddiqui AA, Brown LJ, Hong SK, et al. Relationship of pancreatic mass size and diagnostic yield of endoscopic ultrasound-guided fine needle aspiration. Dig Dis Sci. 2011;56:3370–5.

    PubMed  Google Scholar 

  68. Haba S, Yamao K, Bhatia V, et al. Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions: Japanese large single center experience. J Gastroenterol. 2013;48:973–81.

    PubMed  Google Scholar 

  69. Kurita A, Kodama Y, Nakamoto Y, et al. Impact of EUS-FNA for preoperative para-aortic lymph node staging in patients with pancreatobiliary cancer. Gastrointest Endosc. 2016;84:467–75.

    PubMed  Google Scholar 

  70. Hou X, Jin Z, Xu C, et al. Contrast-enhanced harmonic endoscopic ultrasound-guided fine-needle aspiration in the diagnosis of solid pancreatic lesions: a retrospective study. PLoS One. 2015;10:e0121236.

    PubMed  PubMed Central  Google Scholar 

  71. Kamata K, Takenaka M, Omoto S, et al. Impact of avascular areas, as measured by contrast-enhanced harmonic EUS, on the accuracy of FNA for pancreatic adenocarcinoma. Gastrointest Endosc. 2018;87:158–63.

    PubMed  Google Scholar 

Download references

Acknowledgements

The present study was supported by grants from the Japan Society for Promotion of Science.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masayuki Kitano.

Ethics declarations

Ethical statements

As this is a review article based on published literature, no ethics approval was required.

Conflict of interest

Masayuki Kitano has received honoraria for speaking lectures at conferences from Olympus Corporation.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamashita, Y., Kitano, M. Endoscopic ultrasonography for pancreatic solid lesions. J Med Ultrasonics 47, 377–387 (2020). https://doi.org/10.1007/s10396-019-00959-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10396-019-00959-x

Keywords

Navigation